Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Brain Res. 2016 May 25;1646:139–151. doi: 10.1016/j.brainres.2016.05.026

Table 1.

Human subject list with pathological scores.

ID Age Sex APOE PMD Diagnoses B&B stage Atherosclerosis* Amyloid angiopathy* Other pathology
591 78 F 33 5.5 Normal CERAD 1A 1
673 80 F 33 1.2 Normal CERAD 1A 1 Mild
981 74 F 24 4.7 Normal CERAD 1B 3 Metastatic Carcinoma
1035 72 F 33 30 Normal CERAD 1B 2
196 75 M 33 18.9 Normal CERAD 1B 1
381 78 M n/a 9.8 Normal CERAD 1A 1
837 75 M 22 29 Normal CERAD 1A 1 Lacunes
543 72 F 34 3 Normal CERAD 1A 1
707 80 M 33 4.3 Normal CERAD 1B 1
795 81 M 34 7.2 Normal CERAD 1B 1 Lacunes
357 75 M 33 3 AD 3 Mild
347 77 M 33 16.8 AD 3
601 76 F 33 10.5 AD 3
602 78 M 34 0.8 AD 3 Mild
731 76 F 44 5.5 AD 3 Mild Mild
1054 75 F 34 20.1 AD 3 Severe Mild
1052 71 M 33 25.2 AD 6 Mild
1068 77 M 44 25.4 AD 6 Mild Mild
1560 74 F 34 20.5 AD 6
360 75 F 33 13.3 AD 6 Mild
1664 79 F n/a 20.8 AD 6 Moderate Infarcts
49 75 F 34 24 AD 6 Severe
254 75 M 34 2.6 AD 6 Moderate
*

Pathological scores were analyzed by a pathologist for atherosclerosis and amyloid angiopathy using CERAD guidelines and NIA-Reagan criteria